PNC-27 is an experimental synthetic peptide (27 amino acids long) derived from the p53 protein’s C-terminal domain, fused with a penetratin sequence for cell penetration. It’s primarily researched for its potential oncolytic (cancer-killing) properties by targeting cancer cell membranes, inducing necrosis (cell death) without harming healthy cells. Here’s a breakdown based on available scientific literature and studies:

Key Mechanism

• Selective Action: Binds to HDM-2 (an oncoprotein overexpressed in many cancers), forming pores in the cancer cell membrane. This leads to rapid necrosis, often within hours.
• Cancer Types Studied: Effective in preclinical models against pancreatic cancer, breast cancer, leukemia, melanoma, glioblastoma, and others. Lab tests show it kills 90-100% of cancer cells at low doses (e.g., 50-100 μg/mL) while sparing normal cells.
• Evidence:
  • Peer-reviewed papers (e.g., Anticancer Research, 2007; Investigational New Drugs, 2013) from researchers like Dr. Matthew F. McCarty demonstrate membrane disruption via electron microscopy and cytotoxicity assays.
  • In vitro/in vivo mouse studies show tumor regression without systemic toxicity.

10mg Dosage Context

• Research Use Only: A 10mg vial is a common size sold by peptide suppliers (e.g., for lab/research purposes). It’s not FDA-approved for human use—purely experimental.
• Typical Prep: Reconstituted in bacteriostatic water (e.g., 2-5mL) for ~2-5mg/mL stock. Research doses in studies: 10-100μg/kg IV/SC in animals; human anecdotal reports (unverified) suggest 100-500μg injections, but no clinical trials exist.
• Purity/Stability: High-purity (≥98%) lyophilized powder; store at -20°C. Half-life ~hours in vivo.

Availability & Legality

Current Status & Caveats

• No Clinical Trials: Phase I stalled; still preclinical. Not a proven treatment—hype comes from bodybuilding/alt-med communities claiming anti-cancer benefits (unsupported).
• Alternatives: Standard cancer therapies (chemo, immunotherapy) have proven data.
• Advice: Consult a doctor before any use. Self-administration is risky and illegal in many contexts.

Potential Side Effects (From Studies) FOR PNC-27 10MG

• Animal Data: Mild injection site irritation; no organ toxicity (liver/kidney histo normal).
• Theoretical Risks: Cytokine release (fever-like), immune response to foreign peptide.
• No Data On: Pregnancy, chronic use, combos with immunotherapy.

Sourcing & Quality Check

• Reputable Vendors: Peptide Sciences (COA provided), SwissChems, PureRawz. Avoid Alibaba unknowns.
• Verify: HPLC/MS certificate (purity >98%), endotoxin <1EU/mg.
• Cost: $80-120/10mg (bulk discounts).

Ongoing Developments

• Trials? None active (ClinicalTrials.gov: zero). Dr. McCarty’s group (NutraSci) holds IP; stalled due to funding.
• Community Buzz: Forums like Reddit (r/Peptides) report “miracle” anecdotes for terminal cases—unverified, placebo possible.
• Future: Could pair with CAR-T or checkpoint inhibitors for synergy.